Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,620 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment outcomes of stereotactic body radiation therapy using a real-time tumor-tracking radiotherapy system for hepatocellular carcinomas.
Uchinami Y, Katoh N, Abo D, Taguchi H, Yasuda K, Nishioka K, Soyama T, Morita R, Miyamoto N, Suzuki R, Sho T, Nakai M, Ogawa K, Kakisaka T, Orimo T, Kamiyama T, Shimizu S, Aoyama H. Uchinami Y, et al. Among authors: ogawa k. Hepatol Res. 2021 Aug;51(8):870-879. doi: 10.1111/hepr.13649. Epub 2021 May 11. Hepatol Res. 2021. PMID: 33894086 Free article.
Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton.
Uchinami Y, Katoh N, Abo D, Morita R, Taguchi H, Fujita Y, Kanehira T, Suzuki R, Miyamoto N, Takao S, Matsuura T, Sho T, Ogawa K, Orimo T, Kakisaka T, Kobashi K, Aoyama H. Uchinami Y, et al. Among authors: ogawa k. Br J Radiol. 2023 Mar 1;96(1144):20220720. doi: 10.1259/bjr.20220720. Epub 2023 Jan 23. Br J Radiol. 2023. PMID: 36633335 Free PMC article.
Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation.
Chuma M, Taguchi H, Yamamoto Y, Shimizu S, Nakanishi M, Ogawa K, Sho T, Horimoto H, Kobayashi T, Nakai M, Terashita K, Sakuhara Y, Abo D, Tsukuda Y, Tsunematsu S, Hige S, Kato M, Shirato H, Asaka M. Chuma M, et al. Among authors: ogawa k. J Gastroenterol Hepatol. 2011 Jul;26(7):1123-32. doi: 10.1111/j.1440-1746.2011.06745.x. J Gastroenterol Hepatol. 2011. PMID: 21501224
Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
Tsunematsu S, Chuma M, Kamiyama T, Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo H, Kakisaka T, Tsuruga Y, Orimo T, Wakayama K, Ito J, Sato F, Terashita K, Nakai M, Tsukuda Y, Sho T, Suda G, Morikawa K, Natsuizaka M, Nakanishi M, Ogawa K, Taketomi A, Matsuno Y, Sakamoto N. Tsunematsu S, et al. Among authors: ogawa k. Abdom Imaging. 2015 Aug;40(6):1492-9. doi: 10.1007/s00261-015-0352-9. Abdom Imaging. 2015. PMID: 25579172
ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
Terashita K, Chuma M, Hatanaka Y, Hatanaka K, Mitsuhashi T, Yokoo H, Ohmura T, Ishizu H, Muraoka S, Nagasaka A, Tsuji T, Yamamoto Y, Kurauchi N, Shimoyama N, Toyoda H, Kumada T, Kaneoka Y, Maeda A, Ogawa K, Natsuizaka M, Kamachi H, Kakisaka T, Kamiyama T, Taketomi A, Matsuno Y, Sakamoto N. Terashita K, et al. Among authors: ogawa k. J Clin Pathol. 2016 Jul;69(7):593-9. doi: 10.1136/jclinpath-2015-203115. Epub 2015 Dec 15. J Clin Pathol. 2016. PMID: 26670746
Overestimated renal function in patients with liver cirrhosis predicts poor prognosis.
Yoshida S, Suda G, Ohara M, Kimura M, Yang Z, Maehara O, Fu Q, Hosoda S, Akinori K, Tokuchi Y, Yamada R, Kitagataya T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Sakamoto N. Yoshida S, et al. Among authors: ogawa k. Hepatol Res. 2022 Jul;52(7):603-613. doi: 10.1111/hepr.13765. Epub 2022 Apr 19. Hepatol Res. 2022. PMID: 35352857
Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.
Suda G, Ogawa K, Kimura M, Maehara O, Kitagataya T, Ohara M, Tokuchi Y, Kubo A, Yamada R, Shigesawa T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Sakamoto N. Suda G, et al. Among authors: ogawa k. Hepatol Res. 2020 Oct;50(10):1196-1200. doi: 10.1111/hepr.13551. Epub 2020 Aug 14. Hepatol Res. 2020. PMID: 32729953
Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma.
Ohara M, Suda G, Kohya R, Sasaki T, Yoda T, Yoshida S, Fu Q, Yang Z, Hosoda S, Maehara O, Ohnishi S, Tokuchi Y, Kitagataya T, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Ogawa K, Sakamoto N. Ohara M, et al. Among authors: ogawa k. Front Nutr. 2023 Oct 6;10:1272728. doi: 10.3389/fnut.2023.1272728. eCollection 2023. Front Nutr. 2023. PMID: 37867493 Free PMC article.
Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight.
Tokuchi Y, Suda G, Kawagishi N, Ohara M, Kohya R, Sasaki T, Yoda T, Maehara O, Ohnishi S, Kubo A, Yoshida S, Fu Q, Yang Z, Hosoda S, Kitagataya T, Suzuki K, Nakai M, Sho T, Natsuizaka M, Ogawa K, Sakamoto N. Tokuchi Y, et al. Among authors: ogawa k. Hepatol Res. 2023 Jul;53(7):595-606. doi: 10.1111/hepr.13899. Epub 2023 Apr 4. Hepatol Res. 2023. PMID: 36945790
5,620 results